Will drugmakers get what they're looking for at this week's FDA off-label hearing?
FDA and Health Law attorney Joanne Hawana is quoted in this Medical Marketing & Media article on the Food and Drug Administration’s (FDA) off-label hearing. The article discusses possible results from the hearing which could facilitate a regulatory resolution to the off-label pharmaceutical promotion issue between drugmakers and the FDA.
Source